Dry eye, a common condition often manifested with visual

Size: px
Start display at page:

Download "Dry eye, a common condition often manifested with visual"

Transcription

1 Cornea Screening for Meibomian Gland Disease: Its Relation to Dry Eye Subtypes and Symptoms in a Tertiary Referral Clinic in Singapore Louis Tong, 1,2,3 Shyam S. Chaurasia, 2 Jodhbir S. Mehta, 1,2,3 and Roger W. Beuerman 2,4,5 From the 1 Singapore National Eye Center, Singapore; the 2 Singapore Eye Research Institute, Singapore; the 3 Office of Clinical Sciences, Duke-NUS (National University of Singapore) Graduate Medical School, and the 5 Duke-NUS SRP (Signature Research Program) Neuroscience and Behavioral Disorders, Singapore; and the 4 Department of Ophthalmology, Yong Loo Lin School of Medicine, National University Hospital, Singapore. Supported by National Medical Research Council individual research grants NMRC/1206/2009, IBG 2008, NMRC/CSA/013/2009 and a National University of Singapore-Exxon Mobil Award for Clinician Researchers. Submitted for publication August 7, 2009; revised November 9, 2009, and February 2, 2010; accepted February 7, Disclosure: L. Tong, None; S.S. Chaurasia, None; J.S. Mehta, None; R.W. Buerman, None Corresponding author: Louis Tong, Singapore National Eye Center, 11, Third Hospital Avenue, Singapore ; louis.tong.h.t@snec.com.sg. PURPOSE. To study screening methods and associated factors of Meibomian gland disease and dry eye subtypes in a specialized eye clinic in Singapore. METHODS. This cross-sectional study involved 200 patients in a dry eye clinic. The outcome measures evaluated were dysfunctional tear syndrome (DTS) level, meibomian gland disease grade, Schirmer test (ST) result, fluorescein tear break-up time (TBUT), corneal fluorescein staining grade, and irritative eye symptoms. RESULTS. The meibomian gland screening grade was associated with TBUT (P 0.007), especially in the upper eyelid and correlated with reading difficulty (P 0.007) and reversibility of symptomatic blurring with lubricants (P 0.006). An abnormal ST result was associated with early morning discomfort (P 0.001), and reduced TBUT was linked to discomfort in windy conditions (P 0.001). In all patients examined, evaporative dry eye (58%) was the most common type, followed by the mixed evaporative and aqueous tear deficiency (30.5%) types. Fluorescein staining in the central and inferior cornea was most severe in the mixed type. CONCLUSIONS. In dry eye patients, screening for meibomian gland disease based on anteriorization of Marx s line may predict a decrease in TBUT and difficulty in performing certain visual-function related activities. These findings facilitate better understanding of the meibomian gland s contribution to multifactorial dry eye syndrome, apart from routine conventional tests performed in clinics. (Invest Ophthalmol Vis Sci. 2010;51: ) DOI: /iovs Dry eye, a common condition often manifested with visual disturbance and irritative symptoms, 1,2 may be classified as evaporative or hyposecretory, on the basis of the underlying pathologic processes. This classification often neglects patients with concurrent hyperevaporation and hyposecretion. In addition, it is unclear whether patient demographics are unique. There is no definitive single diagnostic test for dry eye, nevertheless, the clinical signs and symptoms of the disorder are important in the diagnosis, assessment of disease progression, and monitoring of treatment outcomes. 3 Currently, it is unclear whether clinical symptoms and signs of dry eye help in evaluating the different aspects of this multifactorial disease. 4 Objective tests for dry eye include the Schirmer test (ST), which measures tear production; tear break-up time (TBUT), which is an indicator of tear film stability; and dye staining tests, which assess ocular surface epithelial damage. Population-based 5,6 and other studies 7 9 have shown that the presence of dry eye symptoms and objective tests demonstrate poor agreement. However, 96% of symptomatic individuals exhibited one abnormal clinical sign. 10 Clearly, more studies are needed to define how symptoms and signs relate to each other. 11 Meibomian gland disease (MGD) is a common condition that is prevalent throughout Asia, (e.g., Taiwan, 57.8% 62.5%, 10 and Thailand, 50%). 12 The Salisbury Eye Study found the prevalence of MGD (based on meibomian gland plugging or collarettes) to be only 3.5% (95% confidence interval [CI]: ). 13 Although MGD is classified as a non dry eye disease in a recent publication of ocular surface disease classification, 3 it has been linked to evaporative dry eye. 14 There have been discrepancies in associating MGD with specific clinical features of dry eye. Results in a Chinese and Taiwanese study showed no correlation of MGD with dry eye symptoms 15 or ST, 16 whereas in the Salisbury Eye Study, MGD was associated with dry eye symptoms. 13 Moreover, several population-based studies reporting dry eye 5,17 19 did not report its relationship with MGD. Recently, a simple method of assessment for MGD based on the position of Marx s line has been proposed. 20 The correlation of this test with dry eye signs and severity, however, remains to be evaluated. We wanted to achieve the following in an Asian dry eye clinic: characterize patients with aqueous deficiency of evaporative or mixed etiologies, analyze the relationship between symptoms and signs, and evaluate a screening test for MGD and its associations with dry eye. METHODS A hospital clinic based, cross-sectional assessment of dry eye patients was conducted in Singapore National Eye Center from 2006 to The study protocol formed part of a routine, ongoing arm of a longterm clinical audit and was approved by the Institutional Review Board of the Singapore Eye Research Institute. All study procedures were performed as part of standard clinical care and complied with the tenets of the Declaration of Helsinki regarding human research, and as all procedures performed were essential for standard clinical care of these patients, written consent was not required, but consent was obtained by assent. The patients were aware of the privacy policy of the hospital that states that information released for publication would not include patient identifiers. Investigative Ophthalmology & Visual Science, July 2010, Vol. 51, No. 7 Copyright Association for Research in Vision and Ophthalmology 3449

2 3450 Tong et al. IOVS, July 2010, Vol. 51, No. 7 There were no uniform criteria for referral to this specialized eye clinic within the Singapore National Eye Center, as individual ophthalmologists exercise their clinical judgment concerning a diagnosis of dry eye. However, the assessment at the clinic was performed by a single ophthalmologist (LT). Data from the first consecutive 200 patients in the clinic with a diagnosis of dry eye were analyzed. Assessment of Predisposing Factors The assessment included a history of dry mouth, previous or current contact lens wear, and known history of diabetes mellitus, rheumatoid arthritis, thyroid disease, or ocular surgery (LASIK or cataract surgery). Use of the following systemic medications was determined by a clinician-administered standardized form: oral contraceptives and hormonal preparations, antihistamines, antispasmodics, and drugs for hypertension, depression, and Parkinsonism. Exposure keratopathy and lid deformity were clinically assessed in addition to an ocular surface examination. Assessment of Dry Eye All patients underwent a TBUT test, grading of corneal fluorescein staining, and ST in that order. TBUT was evaluated by placing a single fluorescein strip over the inferior tear meniscus after shaking off a small drop of normal saline. According to standard instructions, time between eye opening and the first appearance of a dry spot on the cornea was recorded as the TBUT. ST (without anesthesia) was performed by placing a standard strip (Sno Strips; Chauvin, Montpelier, France) over the midlateral one third of the lower lid margin and noting the extent of wetness on the strip after 5 minutes. Spots of corneal fluorescein staining were recorded over the central zone and the superior, inferior, nasal, and temporal quadrants, as described elsewhere. 3 The questionnaire used (Appendix) was adapted from the Ocular Surface Disease Index. 21 All symptoms were graded as 0 (never present) or 1, 2, 3, or 4 (always present-at least once a day in the past week). There were two questions on whether activities (driving a car and computer use) precipitated or aggravated symptoms that were graded 0 (never) to 6 (always aggravated). There were two additional questions on the physical factors (wind or drafts and air conditioning) that may aggravate the symptoms that were graded 0 (never) to 4 (always aggravated). Dry eye was classified according to Delphi Consensus Dysfunctional Tear Syndrome (DTS) levels 22 : DTS I (mildest), II, III, and IV (most severe). Briefly, cases with no corneal fluorescein staining at all, but with symptoms of dry eye, were designated as DTS I; cases with staining but sparing the central zone were designated as DTS II; cases with filaments or staining involving the central zone were designated DTS III; and severe cases with signs, such as opacified corneas or symblepharon, were designated DTS IV. All features in the DTS classification, 22 except conjunctival staining, were considered. The severity of MGD was screened as previously described by using a series of tests: Yamaguchi grading, 20 microscopic signs of MGD, and expressivity of the meibomian glands. Briefly, we designated Yamaguchi grade 0 (least severe) to indicate a posterior location of the mucocutaneous junction (Marx s line), indicated by fluorescein dye staining; grade 3 (most severe) to indicate an anterior position of the Marx s line relative to the meibomian gland (MG) orifices; and grades 1 and 2 to indicate intermediate positions of Marx s line. Two-sectors per eyelid grading, which requires a total of eight assessments of the two eyes of a patient, instead of three-sector grading was adopted to save time in busy ophthalmic clinics. Microscopic signs of MGD include the presence of misdirected lashes, fragility of lashes, scurf formation, irregularity of the MG orifice, loss of expressibility of the MG, and formation of plaques. Expressibility of the MG was assessed by gently squeezing the lower eyelids, and the consistency of the expressed secretion was graded as watery or viscous. Data Analysis The ST results were dichotomized into normal or abnormal ( 8mmin either eye), and the TBUT into normal or abnormal ( 5 seconds), by using previous 4 and other mean-value based thresholds. Evaporative dry eye was defined as abnormal TBUT but normal ST result. Hyposecretory dry eye was defined as normal TBUT and abnormal ST result, and mixed dry eye was defined as abnormal TBUT and ST result. The Yamaguchi score was analyzed for each of the lid sectors, and the total score for each eye amounted to the sum of the individual grades of the four sectors in that eye. Data analysis for categorical and continuous variables was performed with the 2 test and either the t-test or the analysis of variance (ANOVA), respectively (SPSS Inc., Chicago, IL). For significant changes in the ANOVA, post hoc tests with Bonferroni correction were applied. When using ANOVA to analyze the age and the extent of central and inferior corneal fluorescein staining in different dry eye categories, multiple paired comparisons were used in the statistical software. A separate Bonferroni correction was applied, dividing 0.05 by the number of remaining statistical comparisons to obtain a corrected. Because the analyses for each of the three goals of the study (characterization of dry eye subtypes, comparison of symptoms and signs of dry eye, and characterization of MGD) differ in the number of statistical comparisons (3, 26, and 7, respectively), the corrected values were different: 0.05/3 or 0.017, 0.05/26 or and 0.05/7 or , respectively. For logistic regression models with a binary outcome variable, such as a specific dry eye symptom present in 40% of 200 participants, the power of detecting an odds ratio of 1.5 at 0.05 for a single independent variable is ( eugened/ power-samplesize.php). Unless otherwise stated, only one eye (right) of each patient was used in the analyses presented in the results, although we also performed the same analyses to check for consistency with the left eye data. RESULTS Demographics of Dry Eye Clinic Patients The mean age of the patients was years, and 62.5% were women. Eighty seven percent were Chinese and 13% of minority ethnicity (3.5% Asian Indians, 2% Caucasians, 1.5% Malay, and 6% other). Table 1 shows classification into DTS levels. Being female (P 0.006), but not age (P 0.496), was associated with a higher DTS level. Age correlated directly with the total Yamaguchi score (r 0.44, P 0.001) and inversely but weakly correlated with TBUT (r 0.19, P 0.007) and ST result (r 0.16, P 0.026). A history of dry mouth was found in 19.5% of the patients, 11.5% were wearing contact lens currently (at least once in the past week), and 3.5% had worn them in the past. A known history of diabetes mellitus was found in 1.5% of the patients, 3% had rheumatoid arthritis, 5.5% had thyroid disease, and 1.0% had undergone ocular surgery (LASIK or cataract). Seventeen percent of the patients had used one or more systemic medications within the past week. There were no patients with significant exposure keratopathy or lid deformity. Subtypes of Dry Eye Clinic Patients Thirty-four percent and 88.5% of participants had abnormal ST ( 8 mm) and TBUT ( 5 seconds), respectively. Based on these tests, the patients were classified into four categories (Table 2, Fig. 1). Age (P 0.001), but not sex (P 0.36), was associated with the dry eye category (Table 2): The patients who had normal TBUT and ST result had a mean age of years, younger than patients with evaporative dry eye, whose

3 IOVS, July 2010, Vol. 51, No. 7 Dry Eye and Meibomitis 3451 TABLE 1. Dry Eye by Severity Levels DTS 1 DTS 2 DTS 3 Total n (%) 28 (14) 72 (36) 100 (50) 200 (100) Age, mean y SD Females % TBUT, mean s SD ST, mean mm SD Central corneal staining % (n) 0.0 (0) 0.0 (0) 70.0 (70) 35.0 (70) Inferior corneal staining, % (n) 0.0 (0) 72.2 (52) 72.0 (72) 62.0 (124) Symptom score, mean SD* Yamaguchi score, mean SD Total Upper temporal Upper nasal Lower temporal Lower nasal * Calculated by adding the scores for all 12 questions related to dry eye symptoms. The sum of the individual grades of the four sectors in that eye. mean age was years (P 0.006), or mixed dry eye, with a mean age of years (P 0.001). The presence of central cornea fluorescein staining was different between the subtypes of dry eye (P 0.004). The mixed type had more staining (P 0.042) than did the evaporative type, with a mean of spots compared with spots. Inferior corneal staining also varied between dry eye types (P 0.001), with the mixed type showing more staining than the evaporative type (P 0.016) or those with normal ST result and TBUT (P 0.006). The dry eye subtypes had similar individual or total symptom scores (all P 0.05). Relationship between Clinical Features and Dry Eye Severity More severe dry eye (DTS level 3) was associated with a lower ST outcome (P 0.019) and a lower TBUT (P 0.026). The mean ST result in those with and without severe dry eye was and mm, respectively. The mean TBUT in the patients with and without severe dry eye was and seconds, respectively. In clinical terms, these differences were not significant. Table 3 shows that TBUT (using threshold: 3.2 seconds) and inferior corneal staining were the only significant predictors of DTS level 3. The symptom scores (individual or total) were similar between DTS levels (P 0.05). Relationship between Clinical Signs and Symptoms of Dry Eye Pain in the night or on waking up were more frequent in those with abnormal ST findings (P 0.001). Reduced TBUT was linked to discomfort in windy conditions (P 0.001). The total symptom scores were not different between the ST and TBUT categories. The number of staining spots in the inferior cornea was associated with abnormal ST result (P 0.001) but not TBUT (P 0.227). Staining in the central cornea was not associated with ST result (P 0.596) or TBUT (P 0.776). The presence of any corneal fluorescein staining was also not associated with abnormal ST result (P 0.034) or TBUT (P 0.249). The ST result did not correlate with TBUT (r 0.123, P 0.082). Relationship between MGD and Clinical Features of Dry Eye The total Yamaguchi score was associated with decreased TBUT (P 0.007), but not abnormal ST results (P 0.376). When each eyelid segment was analyzed individually, the Yamaguchi score in the upper nasal (P 0.007), but not in the upper temporal, lower temporal, or lower nasal lid segments, was associated with abnormal TBUT. TABLE 2. Dry Eye Subtypes Evaporative Mixed Aqueous Tear Deficiency ST and TBUT Normal P n (%) 116 (58) 61 (30.5) 7 (3.5) 16 (8) Age, mean y SD * Females % TBUT, mean s SD ST, mean mm SD Central corneal staining, % (n) 32.8 (38) 44.3 (27) 42.9 (3) 12.5 (2) Inferior corneal staining, % (n) 62.1 (72) 67.2 (41) 71.4 (5) 37.5 (6) Symptom score, mean SD Yamaguchi score, mean SD Total Upper temporal Upper nasal Lower temporal Lower nasal * P Calculated by adding the scores for all 12 questions related to dry eye symptoms. The sum of the individual grades of the four sectors in that eye.

4 3452 Tong et al. IOVS, July 2010, Vol. 51, No. 7 TABLE 4. Logistic Regression Models with Transient Visual Blurring and Nocturnal/Early Morning Symptoms as Outcome Variables Crude OR Adjusted OR* FIGURE 1. The four subtypes of dry eye patients studied. Top left quadrant: evaporative dry eye; bottom left quadrant: mixed evaporative and hyposecretory dry eye; bottom right quadrant: hyposecretory dry eye; top right quadrant: normal ST result and TBUT. The horizontal and vertical lines indicate conventional thresholds for ST and TBUT, respectively. The percentages indicate the proportion of participants in each group (classification based on right eyes). The total Yamaguchi score correlated weakly with the total symptom score (r 0.151, P 0.032), and correlated only to improvement of vision with artificial tears (r 0.195, P 0.006) and discomfort with reading or driving a car (r 0.191, P 0.007), among individual symptoms. Table 4 shows that having a higher score in the upper eyelids increased the risk of having blurred vision that was correctable with lubricants. Table 5 shows that that sort of score was also associated with difficulty in reading or driving a car. The grades in the lower eyelid segments (data not shown) were not associated with these activities. Microscopic signs of MGD (such as MG plugging) were not associated with ST result or TBUT or with symptoms or staining. DISCUSSION This clinic-based study showed that a simple MGD screening test based on the position of Marx s line in the eyelid was correlated to TBUT and visual functional difficulties. Abnormal Dependent Variable: Blurring of Vision Improving with Artificial Tears Abnormal ST, 8 mm ( ) ( ) Abnormal ST, 13 mm ( ) ( ) Abnormal TBUT, 5 s 0.9 ( ) ( ) Abnormal TBUT, 3 s ( ) ( ) Inferior corneal staining ( ) ( ) Central corneal staining ( ) 1.63 ( ) Yamaguchi score 1.51 ( ) ( ) Right upper temporal Right upper nasal ( ) ( ) Dependent Variable: Burning in Middle of Night or on Waking Abnormal ST, 8 mm ( ) ( ) Abnormal ST, 13 mm ( ) ( ) Abnormal TBUT, 5 s ( ) ( ) Abnormal TBUT, 3 s ( ) ( ) Inferior corneal staining ( ) ( ) Central corneal staining ( ) ( ) Yamaguchi score Right upper temporal ( ) ( ) Right upper nasal 0.96 ( ) ( ) * Adjusted by age, sex. TBUT was associated with discomfort in windy conditions, whereas abnormal ST was associated with early morning or nocturnal discomfort. Fluorescein staining in the central and inferior cornea was most severe in mixed evaporative and hyposecretory dry eye. The sex of the patient, but not the age, was associated with DTS score and age, but not sex, was associated with dry eye category, perhaps because the DTS category is predominantly influenced by the corneal staining, whereas the dry eye category is influenced by ST result and TBUT. Comparison with Previous Studies The advancement of Marx s line observed in the study and its relation to TBUT was consistent with that in previous studies. The MG secretes the lipid layer in human tears 23 and lack of lipid confluence increases evaporation fourfold. 24 Previously, TABLE 3. Multiple Logistic Regressions with Severe Dry Eye (DTS at Least 3) as the Dependent Variable Crude OR Model 1 OR Model 2 OR Abnormal ST, 8 mm ( ) ( ) ( ) Abnormal ST, 13 mm ( ) ( ) ( ) Abnormal TBUT, 5 s ( ) ( ) ( ) Abnormal TBUT, 3 s ( ) ( ) ( ) Inferior corneal staining ( ) ( ) ( ) ( ) Yamaguchi score Upper temporal ( ) ( ) ( ) ( ) Upper nasal ( ) ( ) ( ) ( ) Model 1 was adjusted for age and sex. Model 2 was adjusted for the covariates age, sex, Yamaguchi upper temporal and upper nasal, and inferior corneal fluorescein staining spots, positive TBUT, positive ST result, and inferior corneal staining. Inferior corneal staining and Yamaguchi scores have two odds ratios in Model 2: top row, ST ( 8 mm) and TBUT ( 5 s) as covariates; bottom row: ST ( 13 mm) and TBUT ( 3 s) as covariates. OR, odds ratio.

5 IOVS, July 2010, Vol. 51, No. 7 Dry Eye and Meibomitis 3453 TABLE 5. Logistic Regression Models Showing Reading and Watching Television/Computer Use as Aggravating Factors Crude OR Adjusted OR* Dependent Variable: Irritation with Reading or Driving Abnormal ST, 8 mm ( ) ( ) Abnormal ST, 13 mm ( ) ( ) Abnormal TBUT, 5 s ( ) 2.02 ( ) Abnormal TBUT, 3 s ( ) ( ) Inferior corneal staining ( ) ( ) Central corneal staining 1.07 ( ) 1.03 ( ) Yamaguchi score Right upper temporal ( ) ( ) Right upper nasal ( ) ( ) Dependent Variable: Irritation with Watching Television/Computer Use Abnormal ST, 8 mm ( ) ( ) Abnormal ST, 13 mm ( ) 1.67 ( ) Abnormal TBUT, 5 s ( ) ( ) Abnormal TBUT, 3 s ( ) ( ) Inferior corneal staining ( ) ( ) Central corneal staining ( ) ( ) Yamaguchi Right upper temporal ( ) ( ) Right upper nasal ( ) ( ) * Adjusted by age, sex. the presence of at least one of six dry eye symptoms, but not ST or TBUT, was associated with MGD. 12 In our study, almost all patients had abnormal TBUT but fewer than half had a reduced ST result. A Chinese study 10 found that TBUT was reduced ( 10 seconds) in 79.3% (95% CI, ) whereas only 58.4% (95% CI, ) had a decreased ST result ( 5 mm). In an Australian study, 5 however, abnormal TBUT ( 8 seconds, 8.6%) was less prevalent than abnormal ST ( 8 mm, 16.3%). A Thai study showed similar prevalence of abnormal TBUT ( 10 seconds, 54.7%) and abnormal ST-I ( 10 mm, 50%). 12 Contrary to a previous study, 16 we did not find correlation between the ST and TBUT. These discrepancies between studies originate from differences in thresholds, TBUT and ST techniques used, 3 or from participant differences from population-based studies. Strengths The strength of this study is the thorough assessment of the meibomian glands and dry eye status by a single examiner in a large sample of patients. Greater uniformity and robustness was achieved by prospective data collection. The clinical MGD screening method was based on anatomic changes in MG. 20 Limitations Our data were not compared to normal and MGD cases without dry eye. Therefore, we did not calculate the efficiency of various tests as screening modalities. This deficiency could result in a selection bias. For practical reasons, we did not perform some other tests such as the ST-II (Schirmer s test performed after topical anesthesia application), tear osmolarity, meibography, and meibometry. However, there is no current consensus on the most appropriate diagnostic criteria or combination of criteria. 2,25 Clinical Relevance In clinics with dry eye patients, information on aggravation of symptoms by television viewing or computer use may be used to supplement a diagnosis of evaporative dry eye and MGD. In addition, the Yamaguchi grading may be used to support these diagnoses if slit lamp microscopy is available. These patients may be offered MGD-targeted therapy 14 (reduction of meibomitis-related inflammation), lipid-containing eye drops, education on lid hygiene, warm compresses, doxycycline, and stabilization of tears. 26,27 MGD may be a contributor to dry eye, especially in the evaporative subgroup. A similar opinion has also been sounded in the literature. 22 Since TBUT is abnormal in most of the patients in our study, it is a better single screening tool than ST for detecting dry eye. However, we recommend performing other tests such as ST and Yamaguchi grading to classify dry eye and predict MGD, respectively. MGD assessment may distinguish the predominantly evaporative type of dry eye from the predominantly aqueous-deficient dry eye. It is important in future studies to determine whether the Yamaguchi score correlates with the degree of observed inflammation of the margin of the eyelid as well as the character of the meibum and degree of meibomian gland plugging. CONCLUSIONS In this clinic-based study conducted in Singapore, an MGD screening test based on anteriorization of Marx s line provides clinical information in addition to conventional dry eye tests (i.e., ST result, TBUT, and fluorescein staining) and is associated with reversibility of visual blurring and difficulty in reading. More studies are needed to evaluate MGD screening in people without dry eye. References 1. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143: Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19: Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5: The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5: McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105: Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly: a population-based perspective. Ophthalmology. 1997;104: Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44: Chalmers RL, Begley CG, Edrington T, et al. The agreement between self-assessment and clinician assessment of dry eye severity. Cornea. 2005;24: Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23: Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110: Nichols KK. Patient-reported symptoms in dry dye disease. Ocul Surf. 2006;4: Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25:

6 3454 Tong et al. IOVS, July 2010, Vol. 51, No Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124: Bron A, Tiffany JM. Contribution of Meibomian gland disease to dry eye. Ocul Surf. 2004;2: Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye. 2009;23(3): Lin PY, Cheng CY, Hsu WM, et al. Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci. 2005; 46: Caffery BE, Richter D, Simpson T, Fonn D, Doughty M, Gordon K. CANDEES: The Canadian Dry Eye Epidemiology Study. Adv Exp Med Biol. 1998;438: Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118: Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003; 136: Yamaguchi M, Kutsuna M, Uno T, Zheng X, Kodama T, Ohashi Y. Marx line: fluorescein staining line on the inner lid as indicator of meibomian gland function. Am J Ophthalmol. 2006; 141: Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118: Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006; 25: Mishima S, Maurice DM. The oily layer of the tear film and evaporation from the corneal surface. Exp Eye Res. 1961;1: Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74: Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21: Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137: Sheppard JD. Dry eye moves beyond palliative therapy. Manag Care. 2003;12:6 8. APPENDIX Dry eye questionnaire used in the study: 1. Are your eyes sensitive to light? 2. Do you have a gritty or scratchy sensation in your eyes? 3. Do you have a burning or stinging sensation in your eyes? 4. Do you have blurred vision? 5. Do you have vision fluctuating with blinking? 6. Do you have vision fluctuating with artificial tears? 7. Do you have spontaneous tearing? 8. Do you have pain or burning in the eyes in the middle of the night or on awakening in the morning?

Incidence of dry eye in a sample population in Kuala Lumpur

Incidence of dry eye in a sample population in Kuala Lumpur Incidence of dry eye in a sample population in Kuala Lumpur Bariah Mohd-Ali, Leong Set Fee, Haliza Abdul-Mutalib, Norhani Mohidin Vol. 3 No. 11 (November 2011) International Journal of Collaborative Research

More information

1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India

1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) www.ijmse.com Original Research Article pissn- 2348 4438 eissn-2349-3208

More information

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work?

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/282816021 Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? Conference

More information

Prevalence of Dry Eye in Patients Presenting With Symptoms Suggestive of Dry Eye

Prevalence of Dry Eye in Patients Presenting With Symptoms Suggestive of Dry Eye IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 3 Ver.16 March. (2018), PP 07-12 www.iosrjournals.org Prevalence of Dry Eye in Patients Presenting

More information

JMSCR Vol 05 Issue 02 Page February 2017

JMSCR Vol 05 Issue 02 Page February 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i2.155 Prevalence of Dry Eye Diseases in the

More information

The first comprehensive definition of DED was published in

The first comprehensive definition of DED was published in Special Issue Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions Jun Shimazaki Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital,

More information

Evidence for Technology in the Treatment of Advanced Dry Eye

Evidence for Technology in the Treatment of Advanced Dry Eye Evidence for Technology in the Treatment of Advanced Dry Eye COPE 44435-AS Chris Lievens, OD, MS, FAAO Evidence for Technology in the Treatment of Advanced Dry Eye COPE: 44435-AS Chris Lievens, OD MS FAAO

More information

Evaluation of Dry Eye: A Hospital Based Study

Evaluation of Dry Eye: A Hospital Based Study IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 9 Ver. XI (September. 2017), PP 44-49 www.iosrjournals.org Evaluation of : A Hospital Based

More information

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study Ophthalmology Times Case Study Yasmin Mali, MD Case Study A 57 year old female with presented with ocular irritation and discomfort in both eyes for several months. Patient was previously started on a

More information

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... This Allergan sponsored session was held on July 24, 2005, Hotel Satya Ashoka, Jabalpur. The session was followed

More information

Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study

Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study pissn: 11-8942 eissn: 92-9382 Korean J Ophthalmol 11;25(6):369-374 http://dx.doi.org/.3341/kjo.11.25.6.369 Original Article Cyclosporine.5% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter,

More information

Prevalence of dry eye syndrome in diabetic patients attending Kenyatta National Hospital, Kenya

Prevalence of dry eye syndrome in diabetic patients attending Kenyatta National Hospital, Kenya December December 2015 2015 Journal Journal of Ophthalmology of Ophthalmology of Eastern of Eastern Central Central and Southern and Southern Africa Africa revalence of dry eye syndrome in diabetic patients

More information

Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC

Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC Optimizing the Ocular Surface Presentation Title Presenter Charlene M. Grice, Name MD Carolina Eyecare Physicians, LLC Financial Disclosures I have no financial disclosures. I will discuss off label use

More information

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD Course Description: The Dry Eye Workshop 2 was an assemblage of experts in dry eye disease from around the world,

More information

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK) Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK) David Bruton, Jr. Professor of Ophthalmology Chairman, Department of Ophthalmology The University of Texas Southwestern

More information

Prevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy

Prevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy Al Am een J Med Sci 2015; 8(3):225-229 US National Library of Medicine enlisted journal ISSN 0974-1143 SHORT COMM UN ICAT ION C O D E N : A A J MB G Prevalence of dry eye disease in type 2 diabetic patients

More information

Dry eye syndrome in diabetic children

Dry eye syndrome in diabetic children European Journal of Ophthalmology / Vol. 17 no. 6, 2007 / pp. 873-878 Dry eye syndrome in diabetic children A. AKINCI 1, E. CETINKAYA 2, Z. AYCAN 2 1 Department of Pediatric Ophthalmology 2 Department

More information

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY SURFACE DISEASE DRY EYE DYSFUNCTIONAL TEARS SYND ALLERGIC DISORDERS MEIBOMIAN GLAND PROBLEMS OCULAR IMMUNE

More information

The Epidemiology of Dry Eye Disease

The Epidemiology of Dry Eye Disease The Epidemiology of Dry Eye Disease 2 Fiona Stapleton, Qian Garrett, Colin Chan, and Jennifer P. Craig 2.1 Impact of Dry Eye Disease Dry eye disease (DED) is a common and chronic condition, which is considered

More information

Dry Eye Syndrome (DES)

Dry Eye Syndrome (DES) Dry Eye Syndrome (DES) (1) What is Dry eye syndrome (DES)? (2) What causes dry eye syndrome? (3) What are the features of dry eye syndrome? (ii) Irritation and dry eyes This occurs because without adequate

More information

Dry Eye Prescribing Guidelines

Dry Eye Prescribing Guidelines Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on

More information

Association between Depression and Dry Eye Disease in an Elderly Population METHODS. Subjects. Assessments

Association between Depression and Dry Eye Disease in an Elderly Population METHODS. Subjects. Assessments Cornea Association between Depression and Dry Eye Disease in an Elderly Population Ki Woong Kim, 1,2,3 Sang Beom Han, 3,4,5 Eun Ryung Han, 4 Se Joon Woo, 4 Jung Jae Lee, 6 Jong Chul Yoon, 7 and Joon Young

More information

Dry eye syndrome (DES) is a prevalent condition, with

Dry eye syndrome (DES) is a prevalent condition, with Cornea Comparison of Two Methods for Composite Score Generation in Dry Eye Syndrome Craig See, 1,2 Richard A. Bilonick, 3,4 William Feuer, 2 and Anat Galor 1,2 1 Miami Veterans Administration Medical Center

More information

MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY?

MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY? MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY? Alan G. Kabat, OD, FAAO (901) 252-3691 Memphis, Tennessee alan.kabat@alankabat.com Course description: This course reviews the latest thoughts,

More information

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM Page 1 of 13 BEFORE COMPLETING THE OCULAR EXAMINATION, YOU MUST BE ABLE TO ANSWER YES TO THE FOLLOWING QUESTIONS: Have you done MMP9? (SVonly) The Following are done at Baseline: Have you done Tear Osmolarity?

More information

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Learn Connect Succeed. JCAHPO Regional Meetings 2017 Learn Connect Succeed JCAHPO Regional Meetings 2017 Unveiling Dry Eye Evaluation LOOKING AT DRY EYE DIFFERENTLY: GAINING KNOWLEDGE AND SKILL BY MARTHA TELLO, COMT,OSC, BGS JCAHPO MIAMI, FLORIDA CONTINUING

More information

Dry Eye Disease Is Associated with Deterioration of Mental Health in Male Japanese University Staff

Dry Eye Disease Is Associated with Deterioration of Mental Health in Male Japanese University Staff Tohoku J. Exp. Med., 2014, 233, 215-220 Dry Eye Disease on Mental Health Related Quality of Life 215 Dry Eye Disease Is Associated with Deterioration of Mental Health in Male Japanese University Staff

More information

Topical diquafosol for patients with obstructive meibomian gland dysfunction

Topical diquafosol for patients with obstructive meibomian gland dysfunction BJO Online First, published on April 12, 2013 as 10.1136/bjophthalmol-2012-302668 1 Department of Ophthalmology, Itoh Clinic, Saitama, Japan 2 Department of Ophthalmology, University of Tokyo School of

More information

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6 Dry eye syndrome The aim of this information sheet is to answer any questions you may have about dry eye syndrome. If you have any further questions or concerns, please ask a doctor or nurse caring for

More information

1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation.

1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation. DEWS DRY EYE: DIAGNOSTIC TEST TEMPLATE RAPPORTEUR A.J.Bron 18 th Oct 2004 TEST Mixed tests TO Ocular Irritation / Dry Eye REFERENCES DIAGNOSE VERSION of TEST Multiple tests DESCRIPTION Evaluation of Subjective

More information

Screening of dry eye disease in visual display terminal workers during occupational health examinations: The Moriguchi study

Screening of dry eye disease in visual display terminal workers during occupational health examinations: The Moriguchi study Motoko KAWASHIMA, et al.: Screening of dry eye in visual display terminal workers J Occup Health 2015; 57: 253 258 253 Journal of Occupational Health Screening of dry eye disease in visual display terminal

More information

Meibomian gland Dropout in Chinese cataract patients.

Meibomian gland Dropout in Chinese cataract patients. Biomedical Research 2017; 28 (7): 3072-3077 ISSN 0970-938X www.biomedres.info Meibomian gland Dropout in Chinese cataract patients. Jinling Ge 1,2#, Lian Duan 3#, Chaoqing Wang 2, Xiuhua Zheng 2, Lihua

More information

Tear Osmolarity and its role in Optometric Practice & Contact Lens Success

Tear Osmolarity and its role in Optometric Practice & Contact Lens Success Tear Osmolarity and its role in Optometric Practice & Contact Lens Success Nick Dash: Optometrist Declaration of Association Director: See2wiN Ltd (Accuvision/Visual Edge/SportsVision Institute) Honorary

More information

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE In this article, Christian Roesky, PhD, Chief Executive Officer, Novaliq, discusses the underserved condition of dry eye disease, and presents two products

More information

Meibomian gland dysfunction (MGD) may well be the leading

Meibomian gland dysfunction (MGD) may well be the leading Special Issue The International Workshop on Meibomian Gland Dysfunction: Executive Summary Kelly K. Nichols, 1 Gary N. Foulks, 2 Anthony J. Bron, 3 Ben J. Glasgow, 4,5 Murat Dogru, 6 Kazuo Tsubota, 6 Michael

More information

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Policy Number: 9.03.29 Last Review: 12/2017 Origination: 9/2013 Next Review: 5/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Question 1: Discuss your further examination of this patient with respect to her current symptoms

Question 1: Discuss your further examination of this patient with respect to her current symptoms CASE 10 Patient history 70 year old Asian female Presents to you with persistent irritation, burning, and foreign body sensation in both eyes of several months duration, gradually worsening in severity.

More information

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services. ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you

More information

Efficacy of Topical Pilocarpine in the Management of Primary Aqueous Tear Deficiency: An Initial Study

Efficacy of Topical Pilocarpine in the Management of Primary Aqueous Tear Deficiency: An Initial Study Original Article Efficacy of Topical Pilocarpine in the Management of Primary Aqueous Tear Deficiency: An Initial Study Ma. Theresa B. Urriquia, MD and Jose David F. Marin, Jr., MD Department of Ophthalmology

More information

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Policy Number: 9.03.29 Last Review: 5/2018 Origination: 9/2013 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Scottish Dry Eye Guidelines

Scottish Dry Eye Guidelines Scottish Dry Eye Guidelines VERSION 1.1 September 2018 Scottish Dry Eye Guidelines, version 1.1, September 2018 Contents Contents 1 Introduction 1 Dry Eye Working Group 1 Contributors to Dry Eye Working

More information

Symptom Burden of Patients with Dry Eye Disease: A Four Domain Analysis

Symptom Burden of Patients with Dry Eye Disease: A Four Domain Analysis Symptom Burden of Patients with Dry Eye Disease: A Four Domain Analysis Joelle A. Hallak 1,2 *, Sarmad Jassim 1, Vishakha Khanolkar 1, Sandeep Jain 1 1 Corneal Neurobiology Laboratory, Department of Ophthalmology

More information

Meibomian gland dysfunction

Meibomian gland dysfunction SPECIAL REPORT Meibomian gland dysfunction June 2011 The mere formulation of a problem is far more essential than its solution To raise new questions, new possibilities, to regard old problems from a new

More information

A DRY EYE DISEASE DECISION TREE

A DRY EYE DISEASE DECISION TREE A DRY EYE DISEASE DECISION TREE With the DEWS guidelines almost 10 years old, new approaches are needed. BY JASON SCHMIT, OD I am sometimes asked about medical decision-making by students, interns, fellows,

More information

Conjunctivochalasis (Cch) is described as lax and redundant. The Impact of Conjunctivochalasis on Dry Eye Symptoms and Signs

Conjunctivochalasis (Cch) is described as lax and redundant. The Impact of Conjunctivochalasis on Dry Eye Symptoms and Signs Clinical and Epidemiologic Research The Impact of Conjunctivochalasis on Dry Eye Symptoms and Signs Priyanka Chhadva, 1,2 Abigail Alexander, 1 Allison L. McClellan, 3 Katherine T. McManus, 3 Benjamin Seiden,

More information

The McMonnies questionnaire is often used in the clinical. The Reliability and Validity of McMonnies Dry Eye Index CLINICAL SCIENCES

The McMonnies questionnaire is often used in the clinical. The Reliability and Validity of McMonnies Dry Eye Index CLINICAL SCIENCES CLINICAL SCIENCES The Reliability and Validity of McMonnies Dry Eye Index Kelly K. Nichols, OD, MPH, PhD, Jason J. Nichols, OD, MS, MPH, and G. Lynn Mitchell, MAS Objective: The purpose of this report

More information

A Study of Dry Eye Disorder in Elderly Persons of Western Rajasthan

A Study of Dry Eye Disorder in Elderly Persons of Western Rajasthan Original Article A Study of Dry Eye Disorder in Elderly Persons of Western Rajasthan Avisha Mathur 1, Arvind Chauhan 2 Abstract Introduction: Dry eye syndrome is one of the most frequently encountered

More information

Research Article ABSTRACT INTRODUCTION. Saubhagya Sindhu 1, Shaktibala Dutta 1, Mirza Atif Beg 1, Sanjeev Kumar Mittal 2, Sushobhan Das Gupta 2

Research Article ABSTRACT INTRODUCTION. Saubhagya Sindhu 1, Shaktibala Dutta 1, Mirza Atif Beg 1, Sanjeev Kumar Mittal 2, Sushobhan Das Gupta 2 Research Article Comparative evaluation of topical carboxymethyl cellulose either alone or in combination with topical corticosteroid in the treatment of dry eye in a tertiary-care teaching hospital Saubhagya

More information

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,4 Agent Indication Dosage and Administration Restasis (cyclosporine ophthalmic emulsion)

More information

Financial Disclosures

Financial Disclosures March 19, 2015 Financial Disclosures Consultant: Alcon Allergan Bausch & Lomb Modernizing Medicine Ophthalmologyweb.co m Investor: Novabay Ophthotech Ocular Surface Disease Ocular surface disease is often

More information

BARRY A. SCHECHTER ABSTRACT

BARRY A. SCHECHTER ABSTRACT JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 22, Number 2, 2006 Mary Ann Liebert, Inc. The Evaluation of Ketorolac (Acular LS ) to Improve Patient Comfort During the Induction Phase of Cyclosporin-A

More information

Dry eye disease was recently redefined as a multifactorial

Dry eye disease was recently redefined as a multifactorial CLINICAL SCIENCE Ocular Surface Workup With Automated Noninvasive Measurements for the Diagnosis of Meibomian Gland Dysfunction Giuseppe Giannaccare, MD, PhD,* Luca Vigo, MD, Marco Pellegrini, MD,* Stefano

More information

Impact of Dry Eye Syndrome on Vision-Related Quality of Life in a Non-Clinic-Based General Population

Impact of Dry Eye Syndrome on Vision-Related Quality of Life in a Non-Clinic-Based General Population Le et al. BMC Ophthalmology 2012, 12:22 RESEARCH ARTICLE Open Access Impact of Dry Eye Syndrome on Vision-Related Quality of Life in a Non-Clinic-Based General Population Qihua Le 1, Xiaodong Zhou 2, Ling

More information

Breaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai

Breaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai Lin, Garg Ophthalmology Times 1 Breaking the Cycle Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai Abstract A 32 year-old female with a history of LASIK surgery

More information

HELP HEAL YOUR PATIENTS DRY EYES.

HELP HEAL YOUR PATIENTS DRY EYES. HELP HEAL YOUR PATIENTS DRY EYES. REFRESH REPAIR promotes healing of the cornea and conjunctival epithelia, and improves visual performance in Dry Eye patients. REF115081_v2 12/18 FIRST AND ONLY ARTIFICIAL

More information

1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX drbilltownsend@gmail.com 1 Alcon CIBA Odyssey Medical Science Based Health Shire TearLab Any product

More information

Ocular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It

Ocular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It Advanced Treatment in Ocular Surface Disease Douglas K. Devries, O.D. Eye Care Associates of Nevada Douglas K. Devries Consultant or Speakers Bureau for Allergan AMO TearLab NicOx BVI B&L Disclosures Chronic

More information

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402 Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D. 1409 Kensington Blvd. Bowling Green, OH 43402 Summary As our understanding of dry eye disease has evolved, so

More information

DRY EYE INFORMATION AND TREATMENTS

DRY EYE INFORMATION AND TREATMENTS DRY EYE INFORMATION AND TREATMENTS If you cannot come to your appointment, please call us at least 24 hours before at 450.419.6345. Failure to notify us will result in a $50 fee being charged. Institut

More information

Dry Eye in Diabetes Mellitus Patients and its Relationship with Diabetic Retinopathy

Dry Eye in Diabetes Mellitus Patients and its Relationship with Diabetic Retinopathy Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/571 Dry Eye in Diabetes Mellitus Patients and its Relationship with Diabetic Retinopathy Dr. R S Uma Devi MS 1, Dr.

More information

Colleen Riley, O.D., M.S., F.A.A.O., Graeme Young, M.Phil., Ph.D., F.C.Optom., D.C.L.P., F.A.A.O., and Robin Chalmers, O.D., F.A.A.O.

Colleen Riley, O.D., M.S., F.A.A.O., Graeme Young, M.Phil., Ph.D., F.C.Optom., D.C.L.P., F.A.A.O., and Robin Chalmers, O.D., F.A.A.O. Eye & Contact Lens 32(6): 281 286, 2006 2006 Contact Lens Association of Ophthalmologists, Inc. Prevalence of Ocular Surface Symptoms, Signs, and Uncomfortable Hours of Wear in Contact Lens Wearers: The

More information

Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using an Ocular Surface Interferometer in Nasolacrimal Duct Obstruction Patients

Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using an Ocular Surface Interferometer in Nasolacrimal Duct Obstruction Patients pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2018;32(6):445-450 https://doi.org/10.3341/kjo.2018.0012 Original Article Evaluation of Tear Film Lipid Layer Thickness Measurements Obtained Using

More information

A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction

A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction Ophthalmol Ther (2014) 3:37 48 DOI 10.1007/s40123-014-0025-8 ORIGINAL RESEARCH A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction Hui Shan Sim Andrea Petznick

More information

Microblepharoexfoliation for the Surgical Dry Eye Patient. Frank W. Bowden, III, M.D., FACS

Microblepharoexfoliation for the Surgical Dry Eye Patient. Frank W. Bowden, III, M.D., FACS Microblepharoexfoliation for the Surgical Dry Eye Patient Frank W. Bowden, III, M.D., FACS Disclosures Shire TearScience TearLab RySurg Bausch & Lomb/Valeant BioTissue Surgical Dry Eye The surgical dry

More information

Dry Eye. A Closer Look

Dry Eye. A Closer Look Dry Eye. A Closer Look What is dry eye? Normally, the eye constantly bathes itself in tears. By producing tears at a slow and steady rate, the eye stays moist and comfortable. Sometimes people do not produce

More information

Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel

Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel Int Ophthalmol (2012) 32:229 233 DOI 10.1007/s10792-012-9556-y ORIGINAL PAPER Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon

More information

DRY EYE and MGD. Contact Central Maryland Eye Associates Today.

DRY EYE and MGD. Contact Central Maryland Eye Associates Today. DRY EYE and MGD Contact Central Maryland Eye Associates Today. Now there is an Answer for Millions with Dry Eye There are nearly 30 million people in the United States and over 300 million worldwide who

More information

No Conflict of Interest to Report Charles Stockwell, O.D

No Conflict of Interest to Report Charles Stockwell, O.D OH MY!!! DRY EYE!!! No Conflict of Interest to Report Charles Stockwell, O.D Charles.stockwell@ttuhsc.edu The Problem 1 Filamentary Keratitis Keratoconjunctivitis sicca, or dry eye syndrome, is the most

More information

Current Treatment and Management of Dry Eye

Current Treatment and Management of Dry Eye Current Treatment and Management of Dry Eye David I. Geffen, OD, FAAO David I Geffen, OD, FAAO Consultant/Advisor/Speaker Accufocus Alcon AMO Annidis Bausch + Lomb Bruder Healthcare EyeBrain Optovue Revision

More information

Dry eye syndrome (DES), as defined by

Dry eye syndrome (DES), as defined by Signs and Symptoms in Dry Eye Confirm the diagnosis of dry eye before beginning treatment. BY GIANCARLO MONTANI, OPTOM FIACLE, FBCLA; AND UMBERTO BENELLI, MD, PHD Dry eye syndrome (DES), as defined by

More information

DRY EYE DISEASE is one of

DRY EYE DISEASE is one of CLINICAL SCIENCES Reliability and Validity of the Ocular Surface Disease Index Rhett M. Schiffman, MD, MS; Murray Dale Christianson, MD, FRCSC; Gordon Jacobsen, MS; Jan D. Hirsch, PhD; Brenda L. Reis,

More information

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services. ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you

More information

Advanced Diagnosis and Management of OSD and Tear Dysfunction

Advanced Diagnosis and Management of OSD and Tear Dysfunction Advanced Diagnosis and Management of OSD and Tear Dysfunction Arthur B. Epstein, OD, FAAO Phoenix, Eye Care & The Dry Eye Center of Arizona Phoenix, AZ, USA Our understanding of the ocular surface has

More information

10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye

10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye Evidence for Technology in the Treatment of Dry Eye COPE: 44090-AS Chris Lievens, OD MS FAAO Professor Chief of staff Southern college of optometry Dry eye Chronic Multifactorial Characterized by disturbances

More information

Clinical Study Presence of Dry Eye in Patients with Hashimoto s Thyroiditis

Clinical Study Presence of Dry Eye in Patients with Hashimoto s Thyroiditis Ophthalmology, Article ID 754923, 4 pages http://dx.doi.org/10.1155/2014/754923 Clinical Study Presence of Dry Eye in Patients with Hashimoto s Thyroiditis Emrah Kan, 1 Elif KJlJçkan, 2 Gulçin EcemiG,

More information

Dry Eye Syndrome Prescribing Guidelines

Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome is a group of disorders of the ocular surface related to tear film abnormality, associated with ocular discomfort, visual symptoms and objective

More information

Dry Eye Disease Update

Dry Eye Disease Update Dry Eye Disease Update Feb 2013 Dr. Samuel Kim Director of Physician Training earscience, Inc. skim@tearscience.com Iconoclasts The Dr. Who Drank Infectious Broth, Gave Himself an Ulcer, and Solved a Medical

More information

Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC

Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC Ocular surface disease patients can be very time consuming. You must have a streamlined system and work as a team in order to effectively run a

More information

A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction

A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction CLINICAL SCIENCE A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction Pinnita Prabhasawat, MD, Nattaporn Tesavibul, MD, and Wannaree

More information

Dry eye prevalence and attributable risk factors in the eastern Madhya Pradesh

Dry eye prevalence and attributable risk factors in the eastern Madhya Pradesh Research Article Dry eye prevalence and attributable risk factors in the eastern Madhya Pradesh Pankaj Choudhary, Charudatt Chalisgaonkar, Sujata Lakhtakia, Anamika Dwivedi, Shekhar kain Department of

More information

Dry eye disease (DED) is one of the most common reasons. Decreased Corneal Sensitivity in Patients with Dry Eye

Dry eye disease (DED) is one of the most common reasons. Decreased Corneal Sensitivity in Patients with Dry Eye Decreased Corneal Sensitivity in Patients with Tristan Bourcier, 1,2 M. Carmen Acosta, 2 Vincent Borderie, 1 Fernando Borrás, 3 Juana Gallar, 2 Thierry Bury, 1 Laurent Laroche, 1 and Carlos Belmonte 2

More information

Prevalence of dry eye diseases in a rural and urban population in West Bengal and the role of air pollution.

Prevalence of dry eye diseases in a rural and urban population in West Bengal and the role of air pollution. IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT) e-issn: 2319-2402,p- ISSN: 2319-2399.Volume 8, Issue 6 Ver. III (Jun. 2014), PP 45-50 Prevalence of dry eye diseases

More information

DRY EYE IS ONE OF THE MOST

DRY EYE IS ONE OF THE MOST EPIDEMIOLOGY SECTION EDITOR: LESLIE HYMAN, PhD Prevalence of Dry Eye Disease Among US Men Estimates From the Physicians Health Studies Debra A. Schaumberg, ScD, OD, MPH; Reza Dana, MD, MPH; Julie E. Buring,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular

More information

pat hways Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47

pat hways Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47 pat hways TearLab osmolarity system for diagnosing dry eye disease Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47 Summary The TearLab osmolarity system is a point-of-care

More information

Author's response to reviews

Author's response to reviews Author's response to reviews Title:Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study Authors:

More information

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye Ueda et al. BMC Ophthalmology (2015) 15:58 DOI 10.1186/s12886-015-0040-0 RESEARCH ARTICLE Open Access Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye Kaori

More information

World innovation for dry-eye syndrome using a new pulsed light technology: IRPL

World innovation for dry-eye syndrome using a new pulsed light technology: IRPL World innovation for dry-eye syndrome using a new pulsed light technology: IRPL Meibomian gland dysfunction has been identified to be the main cause of dry eye syndrome around the world These are the words

More information

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease Mun et al. BMC Ophthalmology (2018) 18:237 https://doi.org/10.1186/s12886-018-0910-3 RESEARCH ARTICLE Open Access Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film

More information

pat hways Medtech innovation briefing Published: 21 April 2015 nice.org.uk/guidance/mib29

pat hways Medtech innovation briefing Published: 21 April 2015 nice.org.uk/guidance/mib29 pat hways LipiFlow thermal pulsation treatment for dry eyes es caused by blocked meibomian glands Medtech innovation briefing Published: 21 April 2015 nice.org.uk/guidance/mib29 Summary The LipiFlow system

More information

Dry Eyes The mucin layer

Dry Eyes The mucin layer Dry Eyes Your doctor thinks you may have dry eyes. The tear film is a complex mixture of water and chemicals that moisturize and protect the eye. The tear film also acts as a focusing surface for the eye.

More information

Incidence Of Dry Eye Disesase In People Living With Acquired Immuodeficiency Synrome

Incidence Of Dry Eye Disesase In People Living With Acquired Immuodeficiency Synrome IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 9 Ver. X (September). 2016), PP 41-46 www.iosrjournals.org Incidence Of Dry Eye Disesase In

More information

Assessment of dry eye status in type 2 diabetic patients in tertiary health care hospital, India

Assessment of dry eye status in type 2 diabetic patients in tertiary health care hospital, India IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 13, Issue 8 Ver. IV (Aug. 2014), PP 06-11 Assessment of dry eye status in type 2 diabetic patients in

More information

How to Create a Dry Eye Center

How to Create a Dry Eye Center How to Create a Dry Eye Center Whitney Hauser, OD Signal Ophthalmic Consulting Disclosures TearScience Consultant/Speaker NovaBay Speaker BioTissue - Speaker Lumenis Consultant/Speaker Shire Consultant/Speaker

More information

Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness

Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness Zhao et al. BMC Ophthalmology (2015) 15:53 DOI 10.1186/s12886-015-0036-9 RESEARCH ARTICLE Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness

More information

Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction

Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction Original Research ALI DJALILIAN, MD, EDITOR Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction REIKO ARITA, MD, PHD, 1,2,3,4 NAOYUKI

More information

JMSCR Vol 07 Issue 04 Page April 2019

JMSCR Vol 07 Issue 04 Page April 2019 www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.19 Original Research Article Use of Plasma Rich in Growth Factors

More information

Turnover of Tear Film Lipid Layer/ Mochizuki et al./ page 1. Turnover Rate of Tear Film Lipid Layer Determined by Fluorophotometry

Turnover of Tear Film Lipid Layer/ Mochizuki et al./ page 1. Turnover Rate of Tear Film Lipid Layer Determined by Fluorophotometry BJO Online First, published on August 18, 2009 as 10.1136/bjo.2008.156828 Turnover of Tear Film Lipid Layer/ Mochizuki et al./ page 1 Turnover Rate of Tear Film Lipid Layer Determined by Fluorophotometry

More information

World innovation for dry-eye syndrome using Intense Pulsed Light technology

World innovation for dry-eye syndrome using Intense Pulsed Light technology World innovation for dry-eye syndrome using Intense Pulsed Light technology Meibomian gland dysfunction has been identified to be the main cause of dry eye syndrome around the world. These are the words

More information